vs
Ametek（AME）与OmniAb, Inc.（OABI）财务数据对比。点击上方公司名可切换其他公司
Ametek的季度营收约是OmniAb, Inc.的238.6倍（$2.0B vs $8.4M）。Ametek净利率更高（19.9% vs -169.3%，领先189.2%）。Ametek同比增速更快（13.4% vs -22.5%）。Ametek自由现金流更多（$527.3M vs $-5.7M）。过去两年OmniAb, Inc.的营收复合增速更高（48.4% vs 7.3%）
AMETEK Inc.是美国跨国综合企业，为全球知名的电子仪器及机电设备设计商与制造商，总部位于美国，在全球范围内设有超过150个运营站点，业务覆盖多个国家和地区，为各行业客户提供高性能的相关产品及配套解决方案。
OmniAb, Inc.是一家跨国生物技术企业，拥有专利转基因动物平台及全流程抗体发现解决方案，与全球制药和生物科技公司合作，加速肿瘤、自身免疫病等刚需医疗领域的全人源治疗抗体开发。
AME vs OABI — 直观对比
营收规模更大
AME
是对方的238.6倍
$8.4M
营收增速更快
AME
高出35.9%
-22.5%
净利率更高
AME
高出189.2%
-169.3%
自由现金流更多
AME
多$533.0M
$-5.7M
两年增速更快
OABI
近两年复合增速
7.3%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $2.0B | $8.4M |
| 净利润 | $398.6M | $-14.2M |
| 毛利率 | 36.0% | — |
| 营业利润率 | 25.3% | -188.2% |
| 净利率 | 19.9% | -169.3% |
| 营收同比 | 13.4% | -22.5% |
| 净利润同比 | 2.9% | -8.5% |
| 每股收益（稀释后） | $1.73 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMEOABI
| Q4 25 | $2.0B | $8.4M | ||
| Q3 25 | $1.9B | $2.2M | ||
| Q2 25 | $1.8B | $3.9M | ||
| Q1 25 | $1.7B | $4.2M | ||
| Q4 24 | $1.8B | $10.8M | ||
| Q3 24 | $1.7B | $4.2M | ||
| Q2 24 | $1.7B | $7.6M | ||
| Q1 24 | $1.7B | $3.8M |
净利润AMEOABI
| Q4 25 | $398.6M | $-14.2M | ||
| Q3 25 | $371.4M | $-16.5M | ||
| Q2 25 | $358.4M | $-15.9M | ||
| Q1 25 | $351.8M | $-18.2M | ||
| Q4 24 | $387.3M | $-13.1M | ||
| Q3 24 | $340.2M | $-16.4M | ||
| Q2 24 | $337.7M | $-13.6M | ||
| Q1 24 | $310.9M | $-19.0M |
毛利率AMEOABI
| Q4 25 | 36.0% | — | ||
| Q3 25 | 36.3% | — | ||
| Q2 25 | 35.8% | — | ||
| Q1 25 | 36.1% | — | ||
| Q4 24 | 36.6% | — | ||
| Q3 24 | 36.0% | — | ||
| Q2 24 | 36.0% | — | ||
| Q1 24 | 34.1% | — |
营业利润率AMEOABI
| Q4 25 | 25.3% | -188.2% | ||
| Q3 25 | 25.8% | -810.2% | ||
| Q2 25 | 26.0% | -416.2% | ||
| Q1 25 | 26.3% | -453.6% | ||
| Q4 24 | 26.6% | -147.0% | ||
| Q3 24 | 26.1% | -473.7% | ||
| Q2 24 | 25.8% | -214.1% | ||
| Q1 24 | 24.0% | -593.3% |
净利率AMEOABI
| Q4 25 | 19.9% | -169.3% | ||
| Q3 25 | 19.6% | -738.1% | ||
| Q2 25 | 20.2% | -407.4% | ||
| Q1 25 | 20.3% | -438.1% | ||
| Q4 24 | 22.0% | -121.0% | ||
| Q3 24 | 19.9% | -392.4% | ||
| Q2 24 | 19.5% | -179.0% | ||
| Q1 24 | 17.9% | -498.8% |
每股收益（稀释后）AMEOABI
| Q4 25 | $1.73 | $-0.11 | ||
| Q3 25 | $1.60 | $-0.14 | ||
| Q2 25 | $1.55 | $-0.15 | ||
| Q1 25 | $1.52 | $-0.17 | ||
| Q4 24 | $1.67 | $-0.13 | ||
| Q3 24 | $1.47 | $-0.16 | ||
| Q2 24 | $1.45 | $-0.13 | ||
| Q1 24 | $1.34 | $-0.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $458.0M | $25.5M |
| 总债务越低越好 | $2.3B | — |
| 股东权益账面价值 | $10.6B | $267.0M |
| 总资产 | $16.1B | $300.9M |
| 负债/权益比越低杠杆越低 | 0.21× | — |
8季度趋势，按日历期对齐
现金及短期投资AMEOABI
| Q4 25 | $458.0M | $25.5M | ||
| Q3 25 | $439.2M | $28.5M | ||
| Q2 25 | $619.7M | $18.3M | ||
| Q1 25 | $399.0M | $10.9M | ||
| Q4 24 | $374.0M | $27.6M | ||
| Q3 24 | $396.3M | $27.2M | ||
| Q2 24 | $396.6M | $20.8M | ||
| Q1 24 | $373.8M | $19.1M |
总债务AMEOABI
| Q4 25 | $2.3B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AMEOABI
| Q4 25 | $10.6B | $267.0M | ||
| Q3 25 | $10.5B | $277.4M | ||
| Q2 25 | $10.4B | $262.1M | ||
| Q1 25 | $10.0B | $273.5M | ||
| Q4 24 | $9.7B | $287.6M | ||
| Q3 24 | $9.6B | $291.7M | ||
| Q2 24 | $9.3B | $294.2M | ||
| Q1 24 | $9.0B | $301.4M |
总资产AMEOABI
| Q4 25 | $16.1B | $300.9M | ||
| Q3 25 | $16.2B | $309.7M | ||
| Q2 25 | $15.3B | $295.7M | ||
| Q1 25 | $14.9B | $306.2M | ||
| Q4 24 | $14.6B | $325.6M | ||
| Q3 24 | $14.8B | $331.6M | ||
| Q2 24 | $14.8B | $337.3M | ||
| Q1 24 | $14.9B | $352.6M |
负债/权益比AMEOABI
| Q4 25 | 0.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.22× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $584.3M | $-5.7M |
| 自由现金流经营现金流 - 资本支出 | $527.3M | $-5.7M |
| 自由现金流率自由现金流/营收 | 26.4% | -67.8% |
| 资本支出强度资本支出/营收 | 2.9% | 0.1% |
| 现金转化率经营现金流/净利润 | 1.47× | — |
| 过去12个月自由现金流最近4个季度 | $1.7B | $-37.0M |
8季度趋势，按日历期对齐
经营现金流AMEOABI
| Q4 25 | $584.3M | $-5.7M | ||
| Q3 25 | $440.9M | $-9.8M | ||
| Q2 25 | $359.1M | $-5.1M | ||
| Q1 25 | $417.5M | $-15.9M | ||
| Q4 24 | $550.0M | $-3.9M | ||
| Q3 24 | $487.2M | $-6.6M | ||
| Q2 24 | $381.4M | $-12.2M | ||
| Q1 24 | $410.2M | $-17.0M |
自由现金流AMEOABI
| Q4 25 | $527.3M | $-5.7M | ||
| Q3 25 | $420.0M | $-9.9M | ||
| Q2 25 | $329.8M | $-5.3M | ||
| Q1 25 | $394.5M | $-16.1M | ||
| Q4 24 | $498.3M | $-3.9M | ||
| Q3 24 | $460.9M | $-6.7M | ||
| Q2 24 | $360.0M | $-12.9M | ||
| Q1 24 | $382.6M | $-18.0M |
自由现金流率AMEOABI
| Q4 25 | 26.4% | -67.8% | ||
| Q3 25 | 22.2% | -444.2% | ||
| Q2 25 | 18.5% | -136.3% | ||
| Q1 25 | 22.8% | -387.1% | ||
| Q4 24 | 28.3% | -36.3% | ||
| Q3 24 | 27.0% | -161.3% | ||
| Q2 24 | 20.8% | -169.9% | ||
| Q1 24 | 22.0% | -472.5% |
资本支出强度AMEOABI
| Q4 25 | 2.9% | 0.1% | ||
| Q3 25 | 1.1% | 8.1% | ||
| Q2 25 | 1.6% | 4.2% | ||
| Q1 25 | 1.3% | 5.0% | ||
| Q4 24 | 2.9% | 0.4% | ||
| Q3 24 | 1.5% | 3.6% | ||
| Q2 24 | 1.2% | 9.9% | ||
| Q1 24 | 1.6% | 24.4% |
现金转化率AMEOABI
| Q4 25 | 1.47× | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | 1.00× | — | ||
| Q1 25 | 1.19× | — | ||
| Q4 24 | 1.42× | — | ||
| Q3 24 | 1.43× | — | ||
| Q2 24 | 1.13× | — | ||
| Q1 24 | 1.32× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AME
| Transferred At Point In Time | $1.1B | 54% |
| Electronic Instruments Group | $620.1M | 31% |
| Transferred Over Time | $294.6M | 15% |
OABI
暂无分部数据
